Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Fleischmann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2021
General sites of nanoparticle biodistribution as a novel opportunity for nanomedicineDaniel Fleischmann, Achim Goepferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 2, 2020
Biomedical nanoparticle design: What we can learn from virusesSara Maslanka Figueroa, Daniel Fleischmann, Achim Goepferich
Macromolecular Bioscience|February 21, 2020
The Effect of Ligand Mobility on the Cellular Interaction of Multivalent NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
Pharmaceutical Research|February 26, 2020
Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
International Journal of Molecular Sciences|April 3, 2021
Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β PathwayDaniel Fleischmann, Manuela Harloff, Sara Maslanka Figueroa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2019
Influenza A virus mimetic nanoparticles trigger selective cell uptakeSara Maslanka Figueroa, Anika Veser, Kathrin Abstiens, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2020
Nanoparticles Mimicking Viral Cell Recognition Strategies Are Superior Transporters into Mesangial CellsSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
ACS Applied Materials & Interfaces|July 9, 2020
Adenovirus-Mimetic Nanoparticles: Sequential Ligand-Receptor Interplay as a Universal Tool for Enhanced <i>In Vitro</i>/<i>In Vivo</i> Cell IdentificationDaniel Fleischmann, Sara Maslanka Figueroa, Sebastian Beck, et al.
ACS Applied Bio Materials|May 5, 2023
Encapsulation of Pioglitazone into Polymer-Nanoparticles for Potential Treatment of Atherosclerotic DiseasesJonas Groner, Martina Tognazzi, Melanie Walter, et al.
Journal of Drug Targeting|August 22, 2024
Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissueMelanie Walter, Hannah Weißbach, Florian Gembardt, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 4, 2021
General sites of nanoparticle biodistribution as a novel opportunity for nanomedicineDaniel Fleischmann, Achim Goepferich
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 2, 2020
Biomedical nanoparticle design: What we can learn from virusesSara Maslanka Figueroa, Daniel Fleischmann, Achim Goepferich
Macromolecular Bioscience|February 21, 2020
The Effect of Ligand Mobility on the Cellular Interaction of Multivalent NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
Pharmaceutical Research|February 26, 2020
Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer NanoparticlesSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
International Journal of Molecular Sciences|April 3, 2021
Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β PathwayDaniel Fleischmann, Manuela Harloff, Sara Maslanka Figueroa, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2019
Influenza A virus mimetic nanoparticles trigger selective cell uptakeSara Maslanka Figueroa, Anika Veser, Kathrin Abstiens, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2020
Nanoparticles Mimicking Viral Cell Recognition Strategies Are Superior Transporters into Mesangial CellsSara Maslanka Figueroa, Daniel Fleischmann, Sebastian Beck, et al.
ACS Applied Materials & Interfaces|July 9, 2020
Adenovirus-Mimetic Nanoparticles: Sequential Ligand-Receptor Interplay as a Universal Tool for Enhanced <i>In Vitro</i>/<i>In Vivo</i> Cell IdentificationDaniel Fleischmann, Sara Maslanka Figueroa, Sebastian Beck, et al.
ACS Applied Bio Materials|May 5, 2023
Encapsulation of Pioglitazone into Polymer-Nanoparticles for Potential Treatment of Atherosclerotic DiseasesJonas Groner, Martina Tognazzi, Melanie Walter, et al.
Journal of Drug Targeting|August 22, 2024
Long-term residence and efficacy of adenovirus-mimetic nanoparticles in renal target tissueMelanie Walter, Hannah Weißbach, Florian Gembardt, et al.
Pageof 2